Retail sale of pharmaceutical products
AVICENNA PHARMACY AS
Revenue 2024
NOK 18.0m
Operating profit
NOK 1.6m
Equity
NOK 2.6m
Incorporated
2021
Employees
5
Share capital
NOK 60,000
Key figures · 2024
Current ratio
1.53
Equity ratio
41.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 8.8% | |
| Net margin (%%) | 6.9% | |
| Return on assets (%%) | 25.4% | |
| Likviditet | ||
| Current ratio | 1.53 | |
| Working capital | 1.9m | |
| Soliditet | ||
| Equity ratio (%%) | 41.4% | |
| Debt-to-equity ratio | 1.41 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.